These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 21986499)
1. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Liu J; Stevens PD; Li X; Schmidt MD; Gao T Mol Cell Biol; 2011 Dec; 31(24):4917-27. PubMed ID: 21986499 [TBL] [Abstract][Full Text] [Related]
2. mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells. Liu J; Stevens PD; Gao T J Biol Chem; 2011 Feb; 286(8):6510-20. PubMed ID: 21177869 [TBL] [Abstract][Full Text] [Related]
3. PHLPPing through history: a decade in the life of PHLPP phosphatases. Grzechnik AT; Newton AC Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677 [TBL] [Abstract][Full Text] [Related]
4. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling. Warfel NA; Newton AC J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674 [TBL] [Abstract][Full Text] [Related]
5. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563 [TBL] [Abstract][Full Text] [Related]
6. The phosphatase PHLPP controls the cellular levels of protein kinase C. Gao T; Brognard J; Newton AC J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466 [TBL] [Abstract][Full Text] [Related]
7. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C. Xiong X; Li X; Wen YA; Gao T J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826 [TBL] [Abstract][Full Text] [Related]
8. The N-terminal region of p27 inhibits HIF-1α protein translation in ribosomal protein S6-dependent manner by regulating PHLPP-Ras-ERK-p90RSK axis. Zhang D; Liu J; Mi X; Liang Y; Li J; Huang C Cell Death Dis; 2014 Nov; 5(11):e1535. PubMed ID: 25412313 [TBL] [Abstract][Full Text] [Related]
9. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice. Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606 [TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling. Gao S; Duan C; Gao G; Wang X; Yang H Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876 [TBL] [Abstract][Full Text] [Related]
11. S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. Zhang J; Gao Z; Yin J; Quon MJ; Ye J J Biol Chem; 2008 Dec; 283(51):35375-82. PubMed ID: 18952604 [TBL] [Abstract][Full Text] [Related]
12. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL. Rajala RV; Kanan Y; Anderson RE Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440 [TBL] [Abstract][Full Text] [Related]
13. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Liu J; Weiss HL; Rychahou P; Jackson LN; Evers BM; Gao T Oncogene; 2009 Feb; 28(7):994-1004. PubMed ID: 19079341 [TBL] [Abstract][Full Text] [Related]
14. Turning off AKT: PHLPP as a drug target. Newton AC; Trotman LC Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697 [TBL] [Abstract][Full Text] [Related]
15. PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble. Sharma M; Dey CS Cell Commun Signal; 2022 Nov; 20(1):179. PubMed ID: 36376971 [TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway. Palaniappan M; Menon KM Mol Endocrinol; 2010 Sep; 24(9):1782-93. PubMed ID: 20660299 [TBL] [Abstract][Full Text] [Related]
17. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
19. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Brognard J; Sierecki E; Gao T; Newton AC Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267 [TBL] [Abstract][Full Text] [Related]
20. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. Patterson SJ; Han JM; Garcia R; Assi K; Gao T; O'Neill A; Newton AC; Levings MK J Immunol; 2011 May; 186(10):5533-7. PubMed ID: 21498666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]